SnagRx vs RxActivate: Pricing, eligibility, and compounded meds compared
Choosing between SnagRx vs RxActivate comes down to pricing transparency, how medications are sourced, and when you learn total cost. Quick verdict: SnagRx discloses annual-plan pricing up front and promises a price lock across titration; RxActivate requires completion of an eligibility questionnaire and contact details before revealing any pricing.
See SnagRx pricing and plan options
Price disclosure and payment terms
SnagRx posts explicit rates: compounded semaglutide from $69/month and tirzepatide from $119/month on the 12-month plan, with month-to-month equivalents listed as $99 and $149. The advertised $69 and $119 figures are the 12-month plan rates and SnagRx states the rate is locked flat at every dose for the life of treatment. By contrast, RxActivate does not display any price, medication fee, membership fee, shipping charge, cancellation term or billing commitment before the contact-information gate; pricing is gated behind the eligibility flow.
Start RxActivate eligibility flow
Compounded medications and regulatory context
Both providers reference compounded medications in their evidence. SnagRx explicitly describes its offering as compounded semaglutide and compounded tirzepatide and includes a regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. RxActivate states that medication-specific approval status must be confirmed and that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Neither source supplies branded finished-product availability details.
Clinician review, eligibility and state coverage
SnagRx operates with a named clinician network, OpenLoop Health, and states clinicians typically review intake within five hours and always within 24; the SnagRx clinician network covers 48 states. SnagRx says an OpenLoop clinician will meet with an individual after checkout to determine if they qualify and that clinicians retain the decision to prescribe compounded GLP-1s. RxActivate uses a clinician-matched model and runs a two-minute eligibility questionnaire that requests medical and state information; a synthetic test confirmed Alabama service availability. RxActivate requires a licensed clinician to determine that treatment is medically appropriate and displays likely eligibility before requesting contact details.
Review SnagRx clinician and shipping details
Shipping, fulfillment and guarantees
SnagRx states next-day shipping via UPS or FedEx in temperature-controlled packaging for approved orders and offers a full refund if the prescription is declined. SnagRx also advertises a 6-month weight-loss guarantee with terms applied. RxActivate evidence does not display shipping timing, refund or guarantee terms before the contact-information gate; the flow only confirms that eligibility, pricing and state availability are revealed after submission.
Five key differences at a glance
| Criteria | SnagRx | RxActivate |
|---|---|---|
| Price visibility | Semaglutide from $69/month on 12-month plan; month-to-month $99 | Pricing gated; requires contact info and eligibility questionnaire |
| Price structure | Price locked flat at every dose and renewal on plan | Not disclosed before lead capture |
| Medication type | Compounded semaglutide and tirzepatide (not FDA-approved finished products) | Compounded medications may be offered; approval status must be confirmed |
| Clinician model | Named clinician network (OpenLoop Health); typical review within five hours | Clinician-matched plan after two-minute eligibility questionnaire |
| Shipping and guarantees | Next-day shipping in temperature-controlled packaging; full refund if prescription declined; 6-month guarantee (terms apply) | No shipping or guarantee details revealed before contact-information gate |
How the processes compare: intake to treatment
SnagRx captures an intake and states clinicians typically review it quickly and that approved orders ship next-day. RxActivate runs a two-minute questionnaire that requests goals, medication history and safety screening and shows likely eligibility before asking for name, email and phone number; it does not reveal plan or price before contact information is submitted. Both providers emphasize clinician oversight and safety screening, but SnagRx publishes more process and timing details up front while RxActivate emphasizes gated eligibility and clinician matching.
Final verdict and brief recommendation
The primary distinction in SnagRx vs RxActivate is transparency at the point of first contact. SnagRx discloses annual-plan pricing from $69/month for compounded semaglutide and locks that rate across titration, names its clinician network and partner pharmacies, and lists shipping and refund terms. RxActivate requires completion of the eligibility questionnaire and contact details before pricing, fees, shipping or renewal terms are shown; it emphasizes clinician matching and state and safety screening.
Proceed to RxActivate eligibility quiz
Choose SnagRx if…
- You want published 12-month plan pricing up front: semaglutide from $69/month or tirzepatide from $119/month, with a stated price lock across doses.
- You prefer named clinician and pharmacy partners and explicit shipping and refund terms before entering contact details.
Choose RxActivate if…
- You want clinician-matched plans and are willing to complete the eligibility questionnaire and provide contact information to learn pricing, eligibility details and state availability.
Comparison keyword: SnagRx vs RxActivate